BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15578103)

  • 1. Enzyme replacement in Gaucher disease.
    Beutler E
    PLoS Med; 2004 Nov; 1(2):e21. PubMed ID: 15578103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement therapy in type I Gaucher disease.
    Kay AC; Saven A; Garver P; Thurston DW; Rosenbloom BF; Beutler E
    Trans Assoc Am Physicians; 1991; 104():258-64. PubMed ID: 1845151
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosage-response in the treatment of Gaucher disease by enzyme replacement therapy.
    Beutler E
    Blood Cells Mol Dis; 2000 Aug; 26(4):303-6. PubMed ID: 11042031
    [No Abstract]   [Full Text] [Related]  

  • 4. Individualization of long-term enzyme replacement therapy for Gaucher disease.
    Andersson HC; Charrow J; Kaplan P; Mistry P; Pastores GM; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ;
    Genet Med; 2005 Feb; 7(2):105-10. PubMed ID: 15714077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of treating Gaucher disease.
    Beutler E
    Nat Med; 1996 May; 2(5):523-4. PubMed ID: 8616707
    [No Abstract]   [Full Text] [Related]  

  • 6. Gaucher disease with pulmonary involvement in a 6-year-old girl: report of resolution of radiographic abnormalities on increasing dose of imiglucerase.
    Lee SY; Mak AW; Huen KF; Lam ST; Chow CB
    J Pediatr; 2001 Dec; 139(6):862-4. PubMed ID: 11743514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy for mild patients with Gaucher disease.
    Zimran A; Ilan Y; Elstein D
    Am J Hematol; 2009 Apr; 84(4):202-4. PubMed ID: 19229987
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic fractures may develop in Gaucher patients receiving enzyme replacement therapy.
    Sidransky E; Ginns EI; Westman JA; Ehmann WC
    Am J Hematol; 1994 Nov; 47(3):247-9. PubMed ID: 7942798
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease.
    Van Patten SM; Hughes H; Huff MR; Piepenhagen PA; Waire J; Qiu H; Ganesa C; Reczek D; Ward PV; Kutzko JP; Edmunds T
    Glycobiology; 2007 May; 17(5):467-78. PubMed ID: 17251309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended remission of B-cell lymphoma with monoclonal gammopathy in a patient with type 1 Gaucher disease treated with enzyme replacement therapy.
    Camou F; Viallard JF
    Blood Cells Mol Dis; 2012 Jan; 48(1):51-2. PubMed ID: 21983348
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary hypertension in Gaucher's disease.
    Pastores GM; Miller A
    Lancet; 1998 Aug; 352(9127):580. PubMed ID: 9716094
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurological outcome of a patient with Gaucher disease type III treated by enzymatic replacement therapy.
    Dobbelaere D; Sukno S; Defoort-Dhellemmes S; Lamblin MD; Largillière C
    J Inherit Metab Dis; 1998 Feb; 21(1):74-6. PubMed ID: 9501273
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].
    Abe M; Minoguchi M; Jinbo J; Kikuchi Y; Chiba A; Shibata Y; Kogo Y
    Nihon Naika Gakkai Zasshi; 2004 Nov; 93(11):2421-3. PubMed ID: 15624481
    [No Abstract]   [Full Text] [Related]  

  • 14. No justification for very high-dose enzyme therapy for patients with type III Gaucher disease.
    Zimran A; Elstein D
    J Inherit Metab Dis; 2007 Nov; 30(6):843-4. PubMed ID: 18008181
    [No Abstract]   [Full Text] [Related]  

  • 15. Uveitis in Gaucher disease.
    Roos JC
    Am J Ophthalmol; 2006 Feb; 141(2):421; author reply 421-2. PubMed ID: 16458721
    [No Abstract]   [Full Text] [Related]  

  • 16. Enzyme replacement therapy for Gaucher disease in twin pregnancy.
    Malinová V; Poupetová H; Dvoráková L; Zeman J
    Int J Gynaecol Obstet; 2009 Jul; 106(1):64-6. PubMed ID: 19349046
    [No Abstract]   [Full Text] [Related]  

  • 17. Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease.
    Brady RO; Murray GJ; Barton NW
    J Inherit Metab Dis; 1994; 17(4):510-9. PubMed ID: 7967500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment regimens in Gaucher's disease.
    Beutler E
    Lancet; 1995 Aug; 346(8974):581-2. PubMed ID: 7658807
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy.
    de Fost M; van Noesel CJ; Aerts JM; Maas M; Pöll RG; Hollak CE
    Haematologica; 2008 Jul; 93(7):1119-20. PubMed ID: 18519519
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzyme replacement therapy for Gaucher disease.
    Charrow J
    Expert Opin Biol Ther; 2009 Jan; 9(1):121-31. PubMed ID: 19063698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.